Cenobamate Monotherapy for Focal Epilepsy: A Single-Center Retrospective Study.
Zengin Erkam, Erol Ferhat, Gil Guevara Andrea, +1 more·Neurology. Clinical practice
BACKGROUND AND OBJECTIVES: Cenobamate is a novel antiseizure medication (ASM) approved by the Food and Drug Administration for use as adjunctive therapy in focal epilepsy. However, there are limited data on its use as a standalone monotherapy. The aim of our study was to investigate the use of cenobamate monotherapy an…